Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.51), $0.05 better than the analyst estimate of ($1.56). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $6.54 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.